ALADAĞ, M. Et Al. 2018. Efficacy and safety of Ombitasvir, dasabuvir and paritaprevir in cirrhotic cases secondary to HCV. APASL Single topic conference , (İstanbul, Turkey).

ALADAĞ, M., ERDOĞAN, M. A., BİLGİÇ, Y., YILDIRIM, O., ÇAĞIN, Y. F., HARPUTLUOĞLU, M. M. M., ... SEÇKİN, Y.(2018). Efficacy and safety of Ombitasvir, dasabuvir and paritaprevir in cirrhotic cases secondary to HCV . APASL Single topic conference, İstanbul, Turkey

ALADAĞ, MURAT Et Al. "Efficacy and safety of Ombitasvir, dasabuvir and paritaprevir in cirrhotic cases secondary to HCV," APASL Single topic conference, İstanbul, Turkey, 2018

ALADAĞ, MURAT Et Al. "Efficacy and safety of Ombitasvir, dasabuvir and paritaprevir in cirrhotic cases secondary to HCV." APASL Single topic conference , İstanbul, Turkey, 2018

ALADAĞ, M. Et Al. (2018) . "Efficacy and safety of Ombitasvir, dasabuvir and paritaprevir in cirrhotic cases secondary to HCV." APASL Single topic conference , İstanbul, Turkey.

@conferencepaper{conferencepaper, author={MURAT ALADAĞ Et Al. }, title={Efficacy and safety of Ombitasvir, dasabuvir and paritaprevir in cirrhotic cases secondary to HCV}, congress name={APASL Single topic conference}, city={İstanbul}, country={Turkey}, year={2018}}